Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
Status:
Unknown status
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
Stress Disorder (PTSD) is a chronic and debilitating anxiety disorder which is widespread in
every social level and is very prevalent in outpatient and inpatient settings.
A recent open-label study showed that the synthetic cannabinoid receptor agonist Nabilone had
beneficial effects abolishing or greatly reducing nightmares that persisted in spite of
treatment with conventional PTSD medications. Furthermore, a big number of patients suffering
from chronic PTSD report using smoked marijuana because its tranquilizing effect and sleep
quality improvement. According to clinical and epidemiological data different derivates from
the cannabis plant are illegally and pervasively consumed by PTSD patients in order to reduce
distress.
The aim of the proposed study is to broaden the previous observations and to measure the
extent to which Δ 9-THC will bring to significant improvement on the full spectrum of PTSD
symptoms.